Cue Biopharma, Inc. financial data

Symbol
CUE on Nasdaq
Location
40 Guest Street, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 167 % -38.6%
Debt-to-equity 107 % +47.6%
Return On Equity -230 % -61%
Return On Assets -111 % -34.2%
Operating Margin -475 % +18.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 76.8M shares +58%
Common Stock, Shares, Outstanding 76.4M shares +57.2%
Entity Public Float 59.9M USD -61.2%
Common Stock, Value, Issued 76K USD +58.3%
Weighted Average Number of Shares Outstanding, Basic 95.5M shares +90.3%
Weighted Average Number of Shares Outstanding, Diluted 95.5M shares +90.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 8.29M USD -0.11%
Research and Development Expense 33M USD -18.4%
General and Administrative Expense 14.7M USD -7.6%
Operating Income (Loss) -39.4M USD +18.5%
Nonoperating Income (Expense) 488K USD -63.7%
Net Income (Loss) Attributable to Parent -38.9M USD +17.2%
Earnings Per Share, Basic 0 USD/shares +45.9%
Earnings Per Share, Diluted 0 USD/shares +45.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 27.5M USD -8.45%
Accounts Receivable, after Allowance for Credit Loss, Current 532K USD -71.2%
Assets, Current 30.8M USD -9.02%
Property, Plant and Equipment, Net 454K USD -31.9%
Operating Lease, Right-of-Use Asset 5.12M USD +6.4%
Other Assets, Noncurrent 283K USD +155%
Assets 40.7M USD -3.83%
Accounts Payable, Current 3.63M USD -7.14%
Accrued Liabilities, Current 1.52M USD -66.7%
Liabilities, Current 19.3M USD +17%
Operating Lease, Liability, Noncurrent 3.1M USD +58.2%
Liabilities 22.5M USD +8.89%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -363M USD -12%
Stockholders' Equity Attributable to Parent 18.2M USD -16%
Liabilities and Equity 40.7M USD -3.83%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.17M USD +16.5%
Net Cash Provided by (Used in) Financing Activities -1M USD -142%
Net Cash Provided by (Used in) Investing Activities -150K USD -173%
Common Stock, Shares Authorized 300M shares +200%
Common Stock, Shares, Issued 76.4M shares +57.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.32M USD -24.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 90K USD -56.9%
Deferred Tax Assets, Valuation Allowance 94M USD +11.8%
Deferred Tax Assets, Gross 95.2M USD +10.9%
Operating Lease, Liability 5.22M USD +4.07%
Depreciation 383K USD -18%
Payments to Acquire Property, Plant, and Equipment 150K USD +173%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -38.9M USD +17.2%
Lessee, Operating Lease, Liability, to be Paid 5.93M USD +12.1%
Property, Plant and Equipment, Gross 4.33M USD -3.18%
Operating Lease, Liability, Current 2.11M USD -30.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.23M USD -20.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.26M USD -24.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +65.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 709K USD +161%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.88M USD +130%
Deferred Tax Assets, Operating Loss Carryforwards 58.1M USD +8.89%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 3.14M USD +7.21%
Lessee, Operating Lease, Liability, to be Paid, Year Four 558K USD
Operating Lease, Payments 709K USD +139%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.21M USD -32.2%
Share-based Payment Arrangement, Expense 5.75M USD -26.8%
Interest Expense 100K USD -14.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%